WallStreetZenWallStreetZen

NASDAQ: SHC
Sotera Health Co Stock Forecast, Predictions & Price Target

Analyst price target for SHC

Based on 3 analysts offering 12 month price targets for Sotera Health Co.
Min Forecast
$13.00-15.91%
Avg Forecast
$15.67+1.34%
Max Forecast
$17.00+9.96%

Should I buy or sell SHC stock?

Based on 3 analysts offering ratings for Sotera Health Co.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SHC stock forecasts and price targets.

SHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-06
lockedlocked$00.00+00.00%2024-08-06
lockedlocked$00.00+00.00%2024-05-21

1 of 1

Forecast return on equity

Is SHC forecast to generate an efficient return?
Company
N/A
Industry
-4.64%
Market
52.36%

Forecast return on assets

Is SHC forecast to generate an efficient return on assets?
Company
N/A
Industry
11.77%

SHC earnings per share forecast

What is SHC's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.64+354.79%
Avg 2 year Forecast
$0.76+445.21%
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SHC revenue forecast

What is SHC's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.1B+0.64%
Avg 2 year Forecast
$1.2B+7.5%
Avg 3 year Forecast
$1.3B+15.22%
SHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SHC earnings growth forecast

How is SHC forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
133.5%
Industry
24.17%
Market
20.03%
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SHC revenue growth forecast

How is SHC forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
3.81%
Industry
6.01%
Market
8.64%
SHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SHC vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
SHC$15.46$15.67+1.34%Buy
RDNT$66.96$74.75+11.63%Strong Buy
NEOG$14.89$17.50+17.53%Hold
GH$21.35$39.85+86.63%Strong Buy
TWST$42.15$51.63+22.48%Buy

Sotera Health Co Stock Forecast FAQ

Is Sotera Health Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SHC) stock is to Buy SHC stock.

Out of 3 analysts, 1 (33.33%) are recommending SHC as a Strong Buy, 1 (33.33%) are recommending SHC as a Buy, 1 (33.33%) are recommending SHC as a Hold, 0 (0%) are recommending SHC as a Sell, and 0 (0%) are recommending SHC as a Strong Sell.

If you're new to stock investing, here's how to buy Sotera Health Co stock.

What is SHC's earnings growth forecast for 2024-2025?

(NASDAQ: SHC) Sotera Health Co's forecast annual earnings growth rate of 133.5% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 24.17%, and it is also forecast to beat the US market's average forecast earnings growth rate of 20.03%.

Sotera Health Co's earnings in 2024 is $40,098,000.On average, 3 Wall Street analysts forecast SHC's earnings for 2024 to be $180,322,572, with the lowest SHC earnings forecast at $178,425,035, and the highest SHC earnings forecast at $181,257,179.

In 2025, SHC is forecast to generate $216,177,507 in earnings, with the lowest earnings forecast at $212,410,757 and the highest earnings forecast at $218,075,043.

What is SHC's revenue growth forecast for 2024-2026?

(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 3.81% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.64%.

Sotera Health Co's revenue in 2024 is $1,098,186,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2024 to be $313,019,819,352, with the lowest SHC revenue forecast at $312,546,851,401, and the highest SHC revenue forecast at $313,438,976,578. On average, 3 Wall Street analysts forecast SHC's revenue for 2025 to be $334,353,222,878, with the lowest SHC revenue forecast at $332,742,866,129, and the highest SHC revenue forecast at $336,605,909,754.

In 2026, SHC is forecast to generate $358,366,683,721 in revenue, with the lowest revenue forecast at $356,861,399,494 and the highest revenue forecast at $359,871,967,949.

What is SHC's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: SHC) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 11.77%.

What is SHC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SHC price target, the average SHC price target is $15.67, with the highest SHC stock price forecast at $17.00 and the lowest SHC stock price forecast at $13.00.

On average, Wall Street analysts predict that Sotera Health Co's share price could reach $15.67 by Aug 6, 2025. The average Sotera Health Co stock price prediction forecasts a potential upside of 1.34% from the current SHC share price of $15.46.

What is SHC's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: SHC) Sotera Health Co's current Earnings Per Share (EPS) is $0.14. On average, analysts forecast that SHC's EPS will be $0.64 for 2024, with the lowest EPS forecast at $0.63, and the highest EPS forecast at $0.64. In 2025, SHC's EPS is forecast to hit $0.76 (min: $0.75, max: $0.77).

What is SHC's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: SHC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.